Equities

Alfresa Holdings Corp

Alfresa Holdings Corp

Actions
  • Price (USD)11.87
  • Today's Change0.00 / 0.00%
  • Shares traded871.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 20 2024 13:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.

  • Revenue in JPY (TTM)2.89tn
  • Net income in JPY31.77bn
  • Incorporated2003
  • Employees12.52k
  • Location
    Alfresa Holdings Corp23F, Ote Center Bldg., 1-1-3, Ote-machiCHIYODA-KU 100-0004JapanJPN
  • Phone+81 352195100
  • Fax+81 352195103
  • Websitehttps://www.alfresa.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.